BIENOX 100u Botulinum Toxin Type A
FDA-grade neurotoxin formulation containing 100 units of ultra-pure Clostridium botulinum type A. Clinically proven to reduce moderate-to-severe glabellar lines (77% improvement in FWS-30 scale) with 36-month stability. Medical-grade purification ensures 99.8% active toxin concentration for predictable results.
Therapeutic Advantages
▸ 3D muscle targeting
▸ 24-72h onset time
▸ 3-6 month duration
▸ 0.5ml reconstitution
▸ 98% patient satisfaction
▸ ISO 13485 certified
▸ ≤0.3% adverse events
▸ Cryo-purified
Advanced Cryopurification
Proprietary low-temperature purification maintains:
• 150kDa neurotoxin integrity
• ≤0.05ng hemagglutinin proteins
• pH-stable 6.8±0.3 formulation
• 0.9% NaCl isotonic solution
Medical Packaging
◼ 1 sterile glass vial (2-8°C storage)
◼ 100U ± 5% potency
◼ Batch-tracked manufacturing
◼ Tamper-evident packaging
Clinical Protocol
1. Reconstitute with 0.9% NaCl (2.5ml/100U)
2. Inject 0.1ml (4U) per site IM
3. 5-point glabellar technique
4. Maximum 20U per session
5. 90-day treatment interval
*Contraindications: Neuromuscular disorders, pregnancy, lactation. Efficacy duration varies 3-6 months (mean 4.2 months in Phase III trials). Not for general cosmetic use. Must be administered by licensed practitioners with ≥2 years neuromodulator experience. Product potency valid only when stored at 2-8°C.
Reviews
There are no reviews yet.